STEFONI, VITTORIO

STEFONI, VITTORIO  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Ricercatori  

STEFONI V; V. Stefoni  

Risultati 1 - 20 di 98 (tempo di esecuzione: 0.022 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
18 F-FDG PET in malignant lymphoma: significance of positive findings Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. 2005-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 1.01 Articolo in rivista -
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL. 2006-01-01 LEUKEMIA & LYMPHOMA - 1.01 Articolo in rivista -
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L 2020-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi 2016-01-01 CANCER MEDICINE - 1.01 Articolo in rivista cam4.684.pdf
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M. 2008-01-01 CANCER - 1.01 Articolo in rivista -
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M. 2008-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. 2012-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL 2013-01-01 LEUKEMIA & LYMPHOMA - 1.01 Articolo in rivista -
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L. 2022-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista Stefoni2022_Article_BEGEVSalvageRegimenInRelapsedR.pdf
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L. 2020-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience Marangon, Miriam; Tonialini, Lorenzo; Morigi, Alice; Stefoni, Vittorio; Broccoli, Alessandro; Pellegrini, Cinzia; Casadei, Beatrice; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi 2018-01-01 AMERICAN JOURNAL OF HEMATOLOGY - 1.01 Articolo in rivista -
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. Broccoli A; Stefoni V; Faccioli L; Agostinelli C; Spinardi L; Pastore Trossello M; Zinzani P.L. 2012-01-01 RHEUMATOLOGY INTERNATIONAL - 1.01 Articolo in rivista -
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. 2013-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia Broccoli, Alessandro; Bertuzzi, Clara; Fiorentino, Michelangelo; Morigi, Alice; Stefoni, Vittorio; Agostinelli, Claudio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi 2019-01-01 ONCOTARGETS AND THERAPY - 1.01 Articolo in rivista ott-202061-braf-v600e-positive-monomorphic-epitheliotropic-intestinal-t.pdf
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial Zinzani, Pier Luigi; Pellegrini, Cinzia; Chiappella, Annalisa; Di Rocco, Alice; Salvi, Flavia; Cabras, Maria Giuseppina; Argnani, Lisa; Stefoni, Vittorio 2017-01-01 BLOOD - 1.01 Articolo in rivista -
Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, Antonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi 2020-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista haematol.2019.243170.full.pdf
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study Stefoni V.; Pellegrini C.; Argnani L.; Corradini P.; Dodero A.; Orsucci L.; Volpetti S.; Zinzani P.L. 2022-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L. 2021-01-01 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - 1.01 Articolo in rivista -
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi 2019-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding Lolli G.; Broccoli A.; Stefoni V.; Argnani L.; Leone O.; Cavo M.; Zinzani P.L. 2020-01-01 TUMORI - 1.01 Articolo in rivista -